The Mesothelioma Center News - Page 2
Ramucirumab Shows Promise in Mesothelioma Clinical Trial
- by Tim Povtak
- Research & Clinical Trials
- Jun 9, 2020
Patients with pleural mesothelioma cancer experienced a significant survival advantage when ramucirumab, a novel immunotherapy drug, was added to chemotherapy in a treatment regimen. Ramucirumab, marketed by…
Read More
COVID-19 Closures Accelerate Asbestos Abatement in Schools
- by Tim Povtak
- Asbestos Exposure & Bans
- Jun 8, 2020
The COVID-19 pandemic closed educational institutions everywhere, but it also opened a door to the acceleration of vitally important asbestos abatement in schools where children would have been in…
Read More
Health Experts Criticize EPA’s Asbestos Draft Risk Evaluation
- by Tim Povtak
- Asbestos Exposure & Bans
- Jun 2, 2020
Doctors, scientists and occupational health experts from across the country are openly criticizing the U.S. Environmental Protection Agency’s recent asbestos draft risk evaluation. At a virtual press conference arranged…
Read More
Durvalumab Phase III Trial Could Change Mesothelioma Care
- by Tim Povtak
- Research & Clinical Trials
- May 28, 2020
An international, much-anticipated phase III clinical trial that could change standard-of-care treatment for patients with malignant pleural mesothelioma will open soon, pending COVID-19 pandemic restrictions. The randomized trial…
Read More
Mesothelioma Specialist Brings HIPEC Expertise to Stanford
- by Tim Povtak
- Treatment & Doctors
- May 26, 2020
Surgical oncologist and mesothelioma specialist Dr. Byrne Lee spent close to a decade in Southern California, building a well-respected peritoneal surface malignancy program at City of Hope Comprehensive Cancer…
Read More
Johnson & Johnson Ends Talc-Based Baby Powder Sales in US, Canada
- by Tim Povtak
- Asbestos Exposure & Bans
- May 20, 2020
Johnson & Johnson announced Tuesday that it will stop selling its iconic, talc-based baby powder, the target of thousands of lawsuits claiming that its talc was contaminated with asbestos, which…
Read More
New Tests Find Asbestos-Contaminated Talc in Eyeshadow
- by Tim Povtak
- Asbestos Exposure & Bans
- May 19, 2020
The Scientific Analytical Institute in Greensboro, North Carolina, recently uncovered asbestos-contaminated talc in two new eyeshadow makeup products sold online on sites like Amazon and eBay. Its findings were the…
Read More
Libby Protects Those with Asbestos Disease from COVID-19
- by Tim Povtak
- Asbestos Exposure & Bans
- May 13, 2020
No town in America has a higher percentage of asbestos-related lung disease — and resulting respiratory issues — than Libby, Montana, making its population uniquely vulnerable to the COVID-19…
Read More
Report Finds Asbestos, Other Risks in Military Family Housing
- by Tim Povtak
- Asbestos Exposure & Bans
- May 11, 2020
U.S. military families around the world are living in government-owned and -operated housing containing serious health and safety risks, according to the most recent report by the Department of Defense…
Read More
Latest Clinical Trial for Pleural Mesothelioma Opens in Georgia
- by Tim Povtak
- Research & Clinical Trials
- May 6, 2020
Dr. Nagla Abdel Karim of the Georgia Cancer Center has seen the effectiveness of cabozantinib with certain types of thyroid, kidney and liver cancers. She believes it may also work…
Read More
